InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the complete record of transactions filed by Linscott Walt Addison. Director active across 1 company, notably Indaptus Therapeutics, Inc.. Aggregated, 2 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €393. Activity tracked since 7 September 2022. The latest transaction was filed on 22 December 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条